Mild COVID cases mount strong immune defense, study finds
NCT ID NCT04703114
First seen Mar 07, 2026 · Last updated May 14, 2026 · Updated 6 times
Summary
This study enrolled 57 adults with no or mild COVID-19 symptoms to understand how their immune system responds to the virus. Researchers measured immune markers like interferons and cytokines in blood samples. The goal was to see if these patients can clear the virus quickly, unlike severe cases where the immune response may be weaker.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Cochin
Paris, Île-de-France Region, 75014, France
Conditions
Explore the condition pages connected to this study.